Chironji (Buchanania lanzan Spreng.) as an Underexplored Functional Food: Nutritional Value, Bioactivity, Safety and Sustainable Translation

Abstract

Chironji, the edible kernel and fruit of Buchanania lanzan Spreng., occupies an unusual position between a traditional forest food, a high-value nut substitute and a candidate nutraceutical ingredient. Its kernels are energy-dense and contain appreciable lipid and protein, while recent accession-level studies indicate substantial variation in proximate composition, minerals, phenolics and enzyme-inhibitory activity. Yet the evidential basis for functional-food claims remains fragmented. Much of the pharmacological literature concerns concentrated extracts from leaves, bark or roots rather than the edible kernel or fruit matrix, and most reported benefits derive from chemical assays, enzyme inhibition, cell-free systems or small animal experiments. This critical narrative review evaluates the species from resource biology to human-health translation, integrating evidence on germplasm, composition, phytochemistry, processing, biological activity, allergenicity, quality control and livelihood implications. Literature published from 1980 to 20 May 2026 was identified through PubMed, the Directory of Open Access Journals, AGRIS, Crossref metadata and DOI resolution, institutional repositories, broad scholarly web searching and citation chaining; earlier foundational sources were retained where necessary. The strongest evidence supports chironji as a nutrient-rich edible seed with a distinctive lipid-rich matrix and meaningful scope for food diversification. Evidence for antioxidant, glycaemic, immunological, anti-inflammatory or neuroactive effects is biologically plausible but remains preclinical and is not sufficient to establish disease prevention or treatment in humans. Translation is further constrained by inconsistent analytical bases, poorly standardised extracts, limited contaminant and toxicology data, a documented immunoglobulin E-binding allergen, fragile kernels, labour-intensive decortication and dependence on wild or semi-wild resources. Responsible development therefore requires accession-resolved compositional standards, validated processing and storage systems, digestion and bioavailability studies, allergen surveillance, controlled human feeding trials and conservation-linked value chains. Chironji is best regarded as a promising traditional food resource whose nutraceutical potential should be developed through evidence-led product design rather than pharmacological extrapolation.